Senior insider sale
VIKING THERAPEUTICS, INC. — senior position signals high conviction
$2.19M
36.79K shares
What this filing means
SINGLETON J MATTHEW plans to sell 36.79K shares of VIKING THERAPEUTICS, INC. valued at approximately $2.19M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/19/2024ACC: 0000103623-24-000072
Director
Since Jan 2019
36.79K
Shares to sell
$2.19M
Approx. market value
16K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
NQSO
N/A
1/4/2016
16KTotal acquired16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/4/2016 | NQSO N/A | 16K | — |
| Total | 16K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
20.79K
Market value
$1.20M
8/14/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
16K
Market value
$995.4K
8/19/2024
Total
Units
36.79K
Value
$2.19M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/14/2024 | 20.79K | $1.20M | — | Completed |
| Planned — Approximate Date | ||||
8/19/2024 | 16K | $995.4K | NASDAQ | Planned |
| Total | 36.79K | $2.19M | ||